A Comparison of Blood Cellular Indices Between ESRD and a Healthy Ambulatory Population

End Stage Renal Disease (ESRD) is the final stage of chronic kidney disease, with only 10–15% kidney function remaining. Using 2023 data from Loyola University Medical Center, we evaluated 12 blood cellular indices as prognostic markers in ESRD versus healthy controls. Mann-Whitney U Test and Spearman Correlations showed significant differences (p<0.05) in most indices, excluding Platelet-to-Lymphocyte Ratio. Despite cohort variability, these findings highlight the potential of cellular indices as ESRD prognostic tools. This study lays the groundwork for future longitudinal analysis to track disease progression.